Textural Change Following Treatment of Facial Telangiectasias With the Tunable Pulsed-Dye Laser

Treatment of Facial Telangiectasia Using a Dual-Wavelength Laser System (595 and 1,064 nm): A Randomized Controlled Trial with Blinded Response Evaluation

“…The pulsed dye laser (PDL) is presently regarded as the treatment of choice for such superficial vascular lesions. Despite demonstrated treatment efficacy 1,2 and an excellent safety profile, 3 the appearance of purpura that may persist at the treated site for up to 2 weeks has limited patient acceptance. While new longer pulse duration dye lasers have made purpura‐free treatments with the PDL far more common than the treatments using purpuric settings, these have generally proved to be less effective 4 …”

Treatment of Facial Telangiectasia With Variable-Pulse High-Fluence Pulsed-Dye Laser: Comparison of Efficacy with Fluences Immediately Above and Below the Purpura Threshold

“…Among other indications, the pulsed‐dye laser has been used to treat fine telangiectasias and diffuse erythema of the face. Despite treatment efficacy, 1–6 as well as safety that manifests as an exceedingly rare risk of scarring and textural change, 7,8 acceptance by patients has been limited, as difficult to conceal purpura may persist at the treated site for up to 2 weeks 9–11 …”

“…AMONG OTHER indications, the pulsed-dye laser has been used to treat fine telangiectasias and diffuse erythema of the face. Despite treatment efficacy, [1][2][3][4][5][6] as well as safety that manifests as an exceedingly rare risk of scarring and textural change, 7,8 acceptance by patients has been limited, as difficult to conceal purpura may persist at the treated site for up to 2 weeks. [9][10][11] More recently, alternative laser and laser-like devices, such as the pulsed 532-nm frequency-doubled Nd:YAG laser and the intense pulsed light device, have become available that target cutaneous vasculature without inducing purpura.…”

Rapid Recurrence of Keloid after Pulse Dye Laser Treatment

“…Of note, one review of adverse effects in 500 patients treated with the PDL found only atrophic scarring (0.8%), hyperpigmentation (1%), hypopigmentation (2.6%), and dermatitis (2%) but no hypertrophic scarring was noted 17 . Subsequently, however, limited cases with delayed‐onset hypertrophic scarring have been reported 18,19 as have mild scarring and texture changes at higher fluences (12 J/cm 2 ) 20 . More common side effects associated with higher fluences were primarily purpura and pigmentary changes 21 .…”